These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3482992

  • 21. [Effects of the combined antileukemic therapy with various agents on the ultrastructure of the bone marrow cells of patients with myelogeous leukemia].
    Nagao T, Sakamoto T, Saito K, Kitajima K.
    Igaku To Seibutsugaku; 1969 Oct 10; 79(4):167-9. PubMed ID: 5260431
    [No Abstract] [Full Text] [Related]

  • 22. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Cvetanovska G, Blum N, Schaefer HE.
    Mod Pathol; 2000 Aug 10; 13(8):888-96. PubMed ID: 10955456
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy of chronic myelocytic leukemia.
    Galton DA.
    Semin Hematol; 1969 Oct 10; 6(4):323-43. PubMed ID: 4900650
    [No Abstract] [Full Text] [Related]

  • 24. Usefulness of cell kinetics for staging of chronic myeloid leukemia?
    Stryckmans P, Ronge-Collard E, Debusscher L, Peyer A.
    Boll Ist Sieroter Milan; 1978 Jul 31; 57(3):271-7. PubMed ID: 282898
    [Abstract] [Full Text] [Related]

  • 25. Studies on the mechanism of indirubin action in the treatment of chronic granulocytic leukemia. V. Binding between indirubin and DNA and identification of the type of binding.
    Wu GY, Liu JZ, Fang FD, Zuo J.
    Sci Sin B; 1982 Oct 31; 25(10):1071-9. PubMed ID: 6959283
    [Abstract] [Full Text] [Related]

  • 26. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A, Larriba I, Rozman M, Irriguible D, Vallespí T, Aventin A, Ayats R, Millá F, Solé F, Florensa L, Gallart M, Tuset E, Lopez C, Woessner S.
    Haematologica; 2002 Feb 31; 87(2):148-53. PubMed ID: 11836165
    [Abstract] [Full Text] [Related]

  • 27. [Blue histiocytes and Gaucher cells in the spleen and lymph nodes in chronic myelogenous leukemia (author's transl)].
    Hopfner C, Potron G, Adnet JJ, Caulet T, Boy J.
    Nouv Rev Fr Hematol; 1974 Feb 31; 14(5):607-20. PubMed ID: 4141763
    [No Abstract] [Full Text] [Related]

  • 28. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
    Burke JM, Caron PC, Papadopoulos EB, Divgi CR, Sgouros G, Panageas KS, Finn RD, Larson SM, O'Reilly RJ, Scheinberg DA, Jurcic JG.
    Bone Marrow Transplant; 2003 Sep 31; 32(6):549-56. PubMed ID: 12953125
    [Abstract] [Full Text] [Related]

  • 29. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Sep 31; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Sep 31; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 31. The value of bone marrow biopsy in chronic myeloid leukaemia.
    Seewann HL, Lehnert M, Jüttner F.
    Haematologia (Budap); 1983 Sep 31; 16(1-4):67-72. PubMed ID: 6592124
    [Abstract] [Full Text] [Related]

  • 32. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W.
    Acta Med Austriaca Suppl; 1981 Sep 31; 21():1-20. PubMed ID: 6949436
    [Abstract] [Full Text] [Related]

  • 33. Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.
    Vial JP, Tabrizi R, Pigneux A, Lacombe F, Praloran V, Belloc F.
    Cytometry B Clin Cytom; 2006 May 31; 70(3):115-23. PubMed ID: 16572429
    [Abstract] [Full Text] [Related]

  • 34. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ, Elfenbein GJ, Braylan RC, Jones J, Weiner RS.
    Exp Hematol; 1983 Aug 31; 11(7):681-5. PubMed ID: 6350032
    [Abstract] [Full Text] [Related]

  • 35. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
    Lu C, Braine HG, Kaizer H, Saral R, Tutschka PJ, Santos GW.
    Cancer Treat Rep; 1984 May 31; 68(5):711-7. PubMed ID: 6373004
    [Abstract] [Full Text] [Related]

  • 36. In vitro proliferation of normal and leukaemic human leukocytes controlled by an inhibitory endopeptide.
    Balázs A, Mann J, Takácsi-Nagy L, Zimonyi I, Molnár A, Klupp T.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 May 31; 110(1):24-31. PubMed ID: 6192050
    [Abstract] [Full Text] [Related]

  • 37. The long-term results and survival in the treatment of chronic granulocytic leukaemia with Myleran.
    Chrobák L, Radochová D, Chrobáková H.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969 May 31; 12(5):565-70. PubMed ID: 5267593
    [No Abstract] [Full Text] [Related]

  • 38. [Synthesis of some halogenated indirubin derivatives].
    Gu YC, Li GL, Yang YP, Fu JP, Li CZ.
    Yao Xue Xue Bao; 1989 May 31; 24(8):629-32. PubMed ID: 2618709
    [Abstract] [Full Text] [Related]

  • 39. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A, Rosas-Cabral A, Vela-Ojeda J, González JC, Mayani H.
    Leuk Res; 2004 Jun 31; 28(6):639-47. PubMed ID: 15120942
    [Abstract] [Full Text] [Related]

  • 40. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
    Klingemann HG, Eaves CJ, Barnett MJ, Eaves AC, Hogge DE, Nantel SH, Reece E, Shepherd JD, Sutherland HJ, Phillips GL.
    Bone Marrow Transplant; 1994 Sep 31; 14(3):389-96. PubMed ID: 7994260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.